|
Volumn 19, Issue 27, 2001, Pages 3769-3777
|
Contrasting Epstein - Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: Implications for vaccine design
|
Author keywords
CTL epitopes; Epstein Barr virus; Vaccine design
|
Indexed keywords
EPITOPE;
EPSTEIN BARR VIRUS ANTIGEN;
EPSTEIN BARR VIRUS VACCINE;
HLA A2 ANTIGEN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
CASE REPORT;
CONTROLLED STUDY;
CYTOTOXIC T LYMPHOCYTE;
DRUG DESIGN;
EPSTEIN BARR VIRUS;
HUMAN;
HUMAN CELL;
IMMUNE RESPONSE;
IMMUNIZATION;
IMMUNOGENICITY;
INFECTIOUS MONONUCLEOSIS;
MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TRANSGENIC MOUSE;
VACCINE PRODUCTION;
VIRUS INFECTION;
ACUTE DISEASE;
ANIMALS;
ANTIGENS, VIRAL;
CAPSID;
CAPSID PROTEINS;
EPITOPES, T-LYMPHOCYTE;
HERPESVIRUS 4, HUMAN;
HLA-A2 ANTIGEN;
HUMANS;
INFECTIOUS MONONUCLEOSIS;
LEUKOCYTES, MONONUCLEAR;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MICE;
MICE, TRANSGENIC;
T-LYMPHOCYTE SUBSETS;
T-LYMPHOCYTES, CYTOTOXIC;
VIRAL VACCINES;
|
EID: 0035859289
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(01)00085-8 Document Type: Article |
Times cited : (21)
|
References (27)
|